Guardant Health Shares Purchased by First Light Asset Management

Institutional investor boosts stake in cancer diagnostics company

Mar. 16, 2026 at 10:05am

Got story updates? Submit your updates here. ›

First Light Asset Management LLC increased its holdings in Guardant Health, Inc. (NASDAQ:GH) by 117.3% in the 3rd quarter, according to the company's recent 13F filing with the Securities and Exchange Commission. The institutional investor now owns 280,001 shares of the company's stock, making it the 22nd largest position in its investment portfolio.

Why it matters

Guardant Health is a leading provider of liquid biopsy tests for cancer detection and monitoring. The increase in First Light Asset Management's stake suggests the firm sees significant growth potential in the company's technology and market position.

The details

First Light Asset Management now owns approximately 0.22% of Guardant Health, worth $17.5 million as of the most recent SEC filing. The firm added 151,133 shares to its position during the 3rd quarter. Guardant Health's stock has seen significant volatility over the past year, trading between $36.36 and $120.74.

  • First Light Asset Management increased its Guardant Health holdings in the 3rd quarter of 2026.

The players

First Light Asset Management LLC

An institutional investment firm that has increased its stake in Guardant Health, a leading provider of liquid biopsy cancer tests.

Guardant Health, Inc.

A precision oncology company that specializes in blood-based cancer diagnostics, including its flagship Guardant360 next-generation sequencing assay.

Got photos? Submit your photos here. ›

The takeaway

The increased investment by First Light Asset Management underscores the growing importance of liquid biopsy technology in cancer care and the potential for Guardant Health to continue expanding its market share in this rapidly evolving field.